Member Info for Badsterman

Morning all!!

My favourite paragraph;

"Aptamer's ongoing collaboration with AstraZeneca continues to generate compelling data, and multiple pharmaceutical companies have initiated discussions to explore partnerships over the next few months."

Now ain't that something!! 👍

She's up 60% in pre-market too...;

https://stocktwits.com/symbol/LUCY

BELL and LUCY appear to have hit the bottom, GENIP and SALT holding steady with the GUIDENT IPO financials to be published soon.

I need 10p for a profit. It's been long wait, but seems achievable.

It's very quiet here, so my best wishes to any posters still holding. 👍

@Basher;

It wasn't aimed at anyone in particular, just a fact that we don't have DMRE approval, yet. 🤞

Have a good day. 🌞

For those interested;

https://tinyurl.com/4wskdc5t

Sales up and a $220,000 profit, cash burn reduced but still a hefty loss.

However, the Armour and Reebok sales should boost earnings in the next quarter.

Perhaps she's showing signs of life!! 🤣

Aren't you all getting ahead of yourselves?

Yes, the heritage resource body has approved it:

https://www.sahris.org.za/

But KZG are waiting for the official sign off from the Department of Mineral Resources and Energy;

https://www.dmre.gov.za/

The DMRE grant licences, not SAHRIS.

Yeah, this guy.

Lots of resignations, dissolved companies and administrations.

https://find-and-update.company-information.service.gov.uk/officers/JzAELIfnpaXPIZjjnhqdRjwB9KM/appointments

The trouble is Tobias Wilson-Waterworth has a very chequered history. He seems to spend most of his time attending two-bit award ceremonies and off on jollies to Dubai, with his wife.

The 401 deal will go the same way as TRX and 201, a pile of 🐎 💩.

A quickly extended partnership, however there are plenty of companies/institutions involved in drug repurposing.

Using the PDC biobank for the specific purpose of screening non-cancer drugs in cancer applications might provide a quick win.

Mark's doing everything he can to find commercially viable opportunities within a short timeframe. Can't fault his efforts. 👏

Hi Sam,

I've been watching (see link) but nothing filed yet.

https://www.nasdaq.com/market-activity/ipos

Perhaps I'm getting a little ahead of myself, but this is a binding arbitration agreement. Do Arcadia have such a strong legal position?

Dennis seems very capable, he'll already have the next steps planned.

Let's see what Mr Market thinks.....

Poppyseed's research into SAHRIS seems to indicate they've not objected to the Perdevlei development.

This company is really coming together, Dennis Edmonds should be knighted!!

Beautiful,

Gives us the cash to develop Perdevlei, maybe a divi or possibly investment in other projects.

Let's hope Heibei cough up.

Can't deny this is great news, a non invasive Alzheimer’s test for use in a hospital setting!!

Tempered with 12 -18 months development time and the fact that Neuro-Bio have limited resources.

However, they are headed up by Baroness Greenfield, and she is a patron of Alzheimer's Research along with a multitude of professional links in neuroscience.

I reckon 0.5p today, steady as she goes. 👍

Https://www.prnewswire.com/news-releases/innovative-eyewear-partners-with-eye-recommend-expanding-smart-eyewear-access-across-600-independent-optometry-stores-302445429.html

Yes, I know, TEK have a very modest holding in LUCY.

Scroll on by if ya ain't interested.

"Square"...doh!! 🙄

Ironveld just changed their registered address to 33 St James Place today, exactly the same as KZG.

The John Wardle connection?

Hardly a "rat",

Spent three years at Valirx as head of Strategic and Commercial Development and didn't deliver anything (that I'm aware of).

Probably got fired, at least Viera will be pleased (more costcutting!). 🤪

AstraZeneca is discontinuing the CAPItello-280 Phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) in patients with metastatic castration-resistant prostate cancer.

Step forward VAL201!!

Back to waiting....😜

Investors have stopped falling for Cliff's games.

SALT are following in the footsteps of of BELL and LUCY - lots of promises but no commercial viability (approx £1.9 million worth of salt sold, for a £30 million MCAP!).

I predict a SALT raise to follow shortly for "expansion plans" but only once Cliff has sold some of TEK's holding in SALT.

The Guident IPO is my only hope.